Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Enhance MD vs Livea

By GLP-1 ScorecardUpdated

Enhance MD
Site position #4

Higher grade

Livea
Site position #130

Lower grade

Score comparison

Enhance MD has the higher recorded score — 84.8/100 to 69.7/100.

Enhance MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Enhance MD pairs compounded injections with advertised lab testing and care; its four-week supply and 48-week longer plan require a different budget from calendar-month pricing.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueEnhance MD +28
82
54
Dose & formulationEnhance MD +18
82
64
Clinical oversightLivea +5
88
93
Labs & monitoringEnhance MD +17
90
73
FulfillmentEnhance MD +5
84
79
Contract termsEnhance MD +29
84
55
Enhance MD · top barLivea · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricEnhance MDLivea
WeighScore84.8/10069.7/100
GradeBC
Site position#4#130
Semaglutide$249 every 4 weeks on the shortest Core plan; from $212 per 4-week equivalent on a 48-week billed plan (confirm first-order promotion and charge)$99/mo (plus a separate fee, compounded)
Tirzepatide$329 every 4 weeks on the shortest Advanced plan; from $280 per 4-week equivalent on a 48-week billed plan (confirm first-order promotion and charge)$199/mo (compounded)
CoverageFAQ lists 40 states plus DC, subject to product availability; confirm treatment, clinician and pharmacy for your address4 states
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
Enhance MD

Site position #4 · B

Strengths

  • Core and Advanced publish separate short- and longer-plan prices with billing periods stated
  • Product pages advertise care, coaching, supplies and six-month labs; baseline labs are described in onboarding
  • Terms identify independent medical groups and possible pharmacies rather than only a generic provider network
  • The FAQ publishes a product-availability state list and a clinical-ineligibility initial-payment refund policy

What to consider

  • Four-week billing and a 48-week longer plan are not twelve calendar-month payments
  • First-order discounts differ by term; actual debit, dose, quantity and ongoing schedule require confirmation
  • An unused-prepaid-balance refund formula and precise refill cancellation cutoff were not established
  • Pharmacy lists differ across public documents; the assigned dispenser and prescriber remain unknown
  • One disclosed pharmacy has a closed Oklahoma nonresident permit; this limited finding does not establish company closure or the pharmacy assigned to a patient
  • Elite combination and microdose benefit claims were not independently established; no branded or oral GLP-1 offer was established in the reviewed menu
Livea

Site position #130 · C

Strengths

  • LegitScript certified; physician-owned Livea Medical PLLC; Medical Director Dr. Paul Olson, internal medicine/nephrology, 40 years experience
  • Compounded sema from $99/mo and tirz from $199/mo — significantly cheaper than brand Ozempic/Wegovy ($1,000+/mo self-pay)
  • Comprehensive program: InBody scans, registered dietitian nutrition counseling, health coaching, and regular provider check-ins included
  • 15+ years established (founded 2011); 50,000+ clients served; voted Minnesota's Best Weight Loss Program 5 consecutive years
  • Medications shipped to door; same-day consultations; in-person or telehealth; typically HSA/FSA eligible

What to consider

  • Telehealth limited to 4 states only (MN, WI, IA, FL) — unavailable to most of the US; primarily a regional clinic network
  • Pricing ambiguous: $69/mo program fee plus separate medication cost ($99/mo sema) may bring GLP-1 total to ~$168/mo
  • Compounded tirzepatide availability uncertain — FDA announced shortage end in 2026; access subject to eligibility
  • Labs (bloodwork) not explicitly included in any published program tier; confirmed at consultation only
  • Strong MN/WI clinic focus; telehealth reach into IA and FL is newer and less established than core markets

Featured provider

Enhance MD

Enhance MD scores 84.8/100 (B). Enhance MD pairs compounded injections with advertised lab testing and care; its four-week supply and 48-week longer plan require a different budget from calendar-month pricing.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard